Illustration of the mTOR–Sema6D–PPARG signaling pathway in controlling macrophage polarization toward anti-inflammatory (antitumorigenic) phenotype M2 via regulation of fatty acid uptake and metabolic reprogramming

Illustration of the mTOR–Sema6D–PPARγ signaling pathway in controlling macrophage polarization toward anti-inflammatory (antitumorigenic) phenotype M2 via regulation of fatty acid uptake and metabolic reprogramming. mTOR is a critical molecule that controls SEMAD6 expression and regulates the metabolic status of the cell to promote polarization of macrophages. Association of c-Abl tyrosine kinase with SEMA6D with the PXXP region of the cytoplasmic SH3 domain promotes reverse signaling, enhanced by binding plexin-A4. As a result of SEMA6D-driven reverse signaling, PPARγ expression increases and primes metabolic reprogramming events such as fatty acid biosynthesis and fatty acid uptake pathways (CD36, Fabp4). SEMA6D–PPARγ signaling is indispensable for metabolic reprogramming. Abnormalities in this pathway account for impaired fatty acid uptake and metabolic reprogramming, leading to aberrant macrophage polarization. Inhibition of upstream mTOR1/2 with Torin1 or activity of c-Abl tyrosine kinase with dasatinib suppresses the expression of PPARγ and the anti-inflammatory signature genes Arg1 and Chi3l1. Similarly, mutation of the SH3 domain in SEMA6D or absence of SEMA6D accounts for defective anti-inflammatory macrophage polarization (low expression of anti-inflammatory signature genes: Retnla, Il10, and receptors Cd36, Fabp4) along with exaggerated inflammatory responses (IL-12p40, TNF, IL-6). mTOR1/2: mammalian target of rapamycin 1/2; PPARγ: peroxisome proliferator-activated receptor gamma; RXR: retinoid X receptor; PPRE: peroxisome proliferator hormone response elements; LXRα: liver X receptor alpha; Arg1: arginase 1; Chi3l1: chitinase 3 like-1; Retnla: resistin-like molecule alpha; CD36: receptor for lipoproteins; Fabp4: Lp: lipoproteins; FA: fatty acids; LCFA: long-chain fatty acids; BMDMs: bone marrow-derived macrophages. ⟙—inhibition; ↑—upregulation; ↓—downregulation
Illustration of the mTOR–Sema6D–PPARG signaling pathway in controlling macrophage polarization toward anti-inflammatory (antitumorigenic) phenotype M2 via regulation of fatty acid uptake and metabolic reprogramming

Publication

Semaphorin 6 Family—An Important Yet Overlooked Group of Signaling Proteins Involved in Cancerogenesis (2023) Wiktor Wagner, et al. Cancers (Basel). 2023 Dec;15(23). Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates LXR LXR famplex_relations NR1H2 7376
Homo sapiens Primates LXR LXR famplex_relations NR1H3 10062
Homo sapiens Primates SEMA6D SEMA6D ncbigene_symbol SEMA6D 80031
Homo sapiens Primates c-Abl C-ABL ncbigene_synonym ABL1 25
Homo sapiens Primates RXR RXR famplex_relations RXRA 6256
Homo sapiens Primates RXR RXR famplex_relations RXRB 6257
Homo sapiens Primates RXR RXR famplex_relations RXRG 6258
Homo sapiens Primates CD36 CD36 ncbigene_symbol CD36 948
Homo sapiens Primates Fabp4 FABP4 ncbigene_symbol FABP4 2167
Homo sapiens Primates TNF/IL-6 TNF ncbigene_symbol TNF 7124
Homo sapiens Primates TNF/IL-6 IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates IL-10 IL-10 ncbigene_synonym IL10 3586
Homo sapiens Primates Arg1 ARG1 ncbigene_symbol ARG1 383
Homo sapiens Primates Arg1 ARG1 ncbigene_synonym TINAGL1 64129
Homo sapiens Primates Retnia/Pparg PPARG ncbigene_symbol PPARG 5468

Chemical mentions

Word Match MeSH Name ChEBI
Torin1 torin1 1-[4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl]-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one chebi:84327
dasatinib dasatinib 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methylpyrimidin-4-yl]-1-(2-hydroxyethyl)piperazin-1-ium chebi:190514

Disease mentions

Word Match MeSH Name DOID